These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27438183)

  • 21. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
    Asadi-Pooya AA; Hashemzehi Z; Emami M
    Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
    Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A
    Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
    Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
    Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS).
    Xiao F; An D; Deng H; Chen S; Ren J; Zhou D
    Seizure; 2014 Oct; 23(9):756-61. PubMed ID: 24998415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
    Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
    Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
    Ballvé A; Salas-Puig J; Quintana M; Campos D; Llauradó A; Raspall M; Fonseca E; Abraira L; Santamarina E; Toledo M
    Acta Neurol Scand; 2021 Apr; 143(4):407-412. PubMed ID: 33452703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Juvenile myoclonic epilepsy--an underdiagnosed epileptic syndrome].
    Shahar E; Ravid S
    Harefuah; 1996 Nov; 131(9):313-8, 375. PubMed ID: 8981799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Juvenile myoclonic epilepsy].
    Ercegovac MD; Vojvodić N; SokićDV ; Janković SM; Drulović J; Stojsavljević N; Lević Z
    Srp Arh Celok Lek; 1998; 126(9-10):335-44. PubMed ID: 9863404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients.
    Zhang Y; Chen J; Ren J; Liu W; Yang T; Zhou D
    Epilepsia Open; 2019 Jun; 4(2):302-308. PubMed ID: 31168497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.